Japan study finds in-stent restenosis susceptibility markers:
This article was originally published in Clinica
Executive Summary
A Japanese team has identified gene markers that could predict which patients who receive bare metal stents are more likely to develop in-stent restenosis. Researchers from the Gifu Prefectural Tajimi Hospital assessed 461 unrelated Japanese individuals who underwent coronary stent implantation, of which 107 subjects went on to develop in-stent restenosis. The genotypes for 142 polymorphisms of 121 candidate genes were determined using a method that combines polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. The BCHE, GPX1, and ROS1 genotypes were found to be independently associated with in-stent restenosis, the researchers revealed at last week's European Society of Cardiology 2007 meeting in Vienna, Austria.
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.